ArticleOncotarget2018

A plasma telomeric cell-free DNA level in unaffected women with BRCA1 or/and BRCA2 mutations: a pilot study.

Shatovisha Dey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.